Please use this identifier to cite or link to this item: http://essuir.sumdu.edu.ua/handle/123456789/45416
Or use following links to share this resource in social networks: Recommend this item
Title Treating macular edema following RVO
Authors Hrytsay, T.
Keywords retinal vein occlusion
окклюзия вен сетчатки
оклюзія вен сітківки
treatment
лікування
лечение
thrombosis
тромбоз
Type Conference Papers
Date of Issue 2014
URI http://essuir.sumdu.edu.ua/handle/123456789/45416
Publisher Sumy State University
License
Citation Hrytsay, T. Treating macular edema following RVO [Текст] / T. Hrytsay ; EL Adviser N. Horobchenko // To Live in a Safer World : materials of the eighth scientific practical student`s student`s, postgraduate’s and teacher’s of LSNC of the foreign languages department, Sumy, March, 28, 2014 / Відп. за вип. Г.І. Литвиненко. - Sumy : Sumy State University, 2014. - С. 118-119.
Abstract Retinal vein occlusion (RVO) affects 16 million people worldwide, usually the middle-aged or older. It is caused by thrombosis, the clogging of the retinal veins, which may occur in the four branch veins – branch vein retinal occlusion (BVRO), or in the central vein, which is formed by the combination of the four branch veins – central vein retinal occlusion (CVRO). Left untreated (or if treatment fails), persistant RVO can lead to macular edema (ME), the swelling of thickening of the macula caused by leaking blood vessels.
Appears in Collections: Наукові видання (ІФСК)

Views

Canada Canada
1
France France
1
Germany Germany
2
Italy Italy
1
Lithuania Lithuania
1
Sweden Sweden
1
Ukraine Ukraine
205
United Kingdom United Kingdom
456
United States United States
228
Unknown Country Unknown Country
16

Downloads

Canada Canada
1
China China
3
France France
1
Germany Germany
4
Ukraine Ukraine
138
United Kingdom United Kingdom
1
United States United States
1
Unknown Country Unknown Country
15

Files

File Size Format Downloads
Hrytsay_Retinal_vein_occlusion.pdf 424,47 kB Adobe PDF 164

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.